Keyword: treatment
-
Dementia is a degenerative disease that no known drug can completely stop or reverse, despite decades of tests. Now, a historically vilified psychedelic is emerging as a possible new avenue for controlling Alzheimer's symptoms. Neuroscientists around the world are starting to investigate if psilocybin – the psychoactive ingredient in magic mushrooms – can help protect the aging brain. A recent case study in Brazil hints at that tantalizing possibility. It reports that after a patient in her 80s with advanced Alzheimer's disease took a high dose of psilocybin-containing mushrooms, she temporarily regained bladder control and the ability to speak beyond...
-
This is a slightly different kind of post — one grounded in science, but powered by hope.It’s about a breakthrough in the treatment of one of the deadliest cancers we know.Instead of blasting cancer with drugs that make people sick and still don’t improve survival rates, we’re talking about a simple, low-dose treatment approach that researchers believe could help push a deadly brain cancer toward healing rather than destructionResveratrol and copper make brain tumors less aggressiveResearchers studied 20 people with glioblastoma. Ten took a low-dose resveratrol-copper tablet four times a day for about 11 days before brain surgery, while 10...
-
A new drug for pancreatic cancer is showing promise in early testing. Daraxonrasib is a daily pill designed to block cancer signals linked to the RAS gene. It has now finished an early-stage clinical trial — the first time it was tested in people — to evaluate both its safety and effectiveness. The clinical trial, led by the Dana-Farber Cancer Institute and published in The New England Journal of Medicine, tested the drug in 168 patients with advanced pancreatic cancer whose tumors had mutations in the RAS gene. All study participants had previously received at least one chemotherapy treatment.
-
You can’t make this stuff up folks… The World Health Organization (WHO) is now actively advising everyone to NOT take Ivermectin to treat the Hantavirus — because it totally doesn’t work, just like we told you to not take it for COVID or Cancer, so definitely don’t take it ok? Got that? Luckily Forbes even fact-checked it for you and told you it’s true and you should definitely not take Ivermectin for Hantavirus: https://www.forbes.com/sites/maryroeloffs/2026/05/07/no-ivermectin-is-not-proven-to-treat-hantavirus/ Other medical professionals also quickly rejected Bowden’s claims: Dr. Krutika Kuppalli, an internal medicine professor at the University of Texas Southwestern Medical Center, said there is...
-
After nearly 100 years of development, treatments that bolster the body's immune system to fight cancer are coming of age – and saving patients' lives. ---SNIP--- The body has a natural ability to "detect and eliminate cells that look like not-you," explains Karen Knudsen, chief executive of the Parker Institute for Cancer Immunotherapy, a US nonprofit that furthers immunotherapy development. If all is working well, that should include cells that have become cancerous. But sometimes, cancer cells evade or outsmart that system, leading to dangerous unchecked growth. They hide, in plain sight, indistinguishable from the healthy cells around them. Immunotherapy's...
-
Patients with advanced lung cancer who received immunochemotherapy before 15:00 (3 p.m.) had a more delayed disease progression than patients receiving treatment later in the day. The findings, published as part of a randomized phase 3 trial of 210 participants, suggest that scheduling therapy early in the day may offer a simple, cost-neutral way to enhance standard care. Circadian rhythms, the internal 24-hour clock, are known to affect immune cell behavior and responses to treatment. Previous retrospective studies across cancers, such as kidney cancer and malignant melanoma, have hinted that administering immune checkpoint inhibitors earlier in the day might be...
-
People with compromised liver function may be able to reduce their risk of liver cancer or slow its progression with a simple dietary change: eating less protein. A study has found that low-protein diets slowed liver tumor growth and cancer death in mice, uncovering a mechanism by which a liver's impaired waste-handling machinery can inadvertently fuel cancer. When people consume protein, the nitrogen can be converted into ammonia, a substance that's toxic to the body and brain. A healthy liver typically processes this ammonia into harmless urea, which is excreted via urine. To test whether impaired ammonia processing drives cancer...
-
A team of researchers have identified a fundamental mechanism that links the 24-hour circadian cycle to the precise repair of DNA breaks. This study, focused on the circadian protein Cryptochrome1 (CRY1), suggests that the time of day when radiotherapy is administered can significantly influence the effectiveness of treatment for certain types of cancer. It is relatively common for cancer cells to be unable to repair their DNA efficiently. Treatments, such as radiotherapy, exploit this by generating DNA breaks that tumor cells are unable to repair. This study shows DNA break repair in human cells exhibits a circadian oscillation. In a...
-
In December, Marvin Morales‑Ortez walked out of a Fairfax County, Va., jail a free man. He shouldn’t have. Morales‑Ortez was in the country illegally; he was in jail on serious charges, including for a violent assault and a firearm offense. Those charges were dropped. He was released. Within 24 hours, police say, he murdered a man. This was not bad luck. It was policy. Fairfax’s Commonwealth’s Attorney Steve Descano has openly promised to limit or avoid “immigration consequences” when charging criminals. In other words, his office will treat illegal immigrants more leniently than US citizens. Descano’s policy directs his prosecutors...
-
Researchers have identified a metabolically sensitive cell subtype in the eye's drainage system which shows early signs of dysfunction in a genetic mouse model of glaucoma. The study provides a potential therapeutic strategy for preventing or slowing the development of glaucoma. Glaucoma, a group of eye diseases that damage the optic nerve. The main risk factors is high intraocular pressure, which results from dysfunction in the trabecular meshwork—a porous tissue that helps maintain normal eye pressure. Tolman used single-cell RNA sequencing to profile nearly 18,000 cells. They identified six major cell types, with further analysis revealing three subtypes of trabecular...
-
Nick Reiner, who has been charged with the murder of his parents, Rob Reiner and Michele Singer Reiner, was placed into a yearlong mental health conservatorship in 2020, according to two people with knowledge of the legal arrangement.
-
Does this look legit? Alzheimer's Reversal??? +++++++++ WHAT'S WRONG: Your family member has Alzheimer's disease. This is a brain sickness that makes people forget things and get confused. It happens because parts of the brain stop working right. THE GOOD NEWS: +++++++++ Scientists just found new ways to help fix the brain. We now have a plan that uses three different medicines that work together to help the brain get better. HOW THE TREATMENT WORKS: +++++++++ Think of the brain like a house with three problems: PROBLEM 1: The lights are dim The brain cells don't have enough energy Medicine...
-
Scientists have reversed Alzheimer’s disease in mice, potentially showing a pathway to treat the illness among humans, according to a Dec. 22 peer-reviewed study published in the Cell Reports Medicine journal.Alzheimer’s is traditionally considered irreversible. In the study, researchers treated two groups of mice with P7C3-A20, a pharmacologic agent. One group carried human mutations related to amyloid processing, while the other carried a tau protein mutation. Both amyloid and tau pathologies are two major early events of Alzheimer’s. Researchers say that as mice develop brain pathologies resembling Alzheimer’s, they are ideal subjects to test how P7C3-A20 affects Alzheimer’s in humans....
-
[H/T ExTexasRedhead]The Nobel prize winning miracle drug Ivermectin works as an antiviral, anticancer, is part of a Lyme Disease cure protocol, and even reverses dementia, all while having a safety profile that is far superior to aspirin or any “vaccine” for that matter.Cancer surgeon Dr. Kathleen Ruddy had the following to say about Ivermectin:Cancer Surgeon: “Ivermectin Is SAFER Than a Sugar Pill” 👁️“You’d have to take a lot to make yourself sick.”Dr. Kathleen Ruddy has also observed multiple late-stage cancer patients make dramatic recoveries after taking ivermectin.Ivermectin is also:• A Nobel Prize-winning discovery (2015)• Recognized, 2nd to penicillin, for having...
-
A single course of low-dose radiation therapy may provide a safe and effective alternative treatment option for people with painful knee osteoarthritis according to a new randomized, placebo-controlled clinical trial. The study showed patients with mild to moderate knee osteoarthritis reported significant reductions in pain and improved physical function in the four months after receiving the low dose of radiation, which was just a small fraction of what's used to treat cancer. The study included a control group with simulated treatment. Low-dose radiation is regularly used for joint pain in European countries such as Germany and Spain. The doses were...
-
A study has found that a surgical technique developed to protect vision in patients with uveal melanoma, a rare cancer that arises inside the eye, may also lower the risk of the disease spreading and improve survival.. The study followed 37 patients who were treated for uveal melanoma. Most received targeted radiation, known as plaque brachytherapy, combined with a specialized procedure that replaces the eye's gel-like interior with silicone oil, a technique designed to shield healthy parts of the eye from radiation damage while allowing the tumor to receive the full cancer-killing dose. Over a median follow-up of more than...
-
The technique, known as IORT, has numerous benefits, surgeons say, but it generates less money for hospitals and radiation oncologists.It’s not uncommon for breast cancer patients in the rural South to travel hundreds of miles to reach the medical practice run by Dr. Phillip Ley, a cancer surgeon in Jackson, Mississippi. For those who are good candidates, Ley recommends a therapy that delivers a single, targeted radiation dose to a patient’s breast tissue immediately after surgery to remove a tumor. Known as intraoperative radiation therapy, or IORT, it costs patients less in both time and money than traditional radiation treatments,...
-
Colorectal cancer remains a leading cause of cancer death, with incidence rising among older adults. One of the most pressing clinical questions has been whether elderly patients should receive oxaliplatin, a standard component of adjuvant chemotherapy that is known to cause serious side effects. To address this, Dr. Jun Woo Bong conducted a large-scale population study. The team examined health records from more than 8,500 patients with stage II or III colorectal cancer who underwent surgery followed by chemotherapy between 2014 and 2016. Patients were divided into two groups: those treated with oxaliplatin-based combinations, and those given standard chemotherapy alone....
-
A team of researchers explored the cellular and molecular interactions revealing how lymph nodes play a crucial role in the fight against chronic infection and cancer. The research showed that lymph nodes provide the right environment for stem-like T cells, an important type of immune cell, to survive, multiply and produce killer cells that can fight cancer or viruses. In other immune organs, such as the spleen, these cells don't develop or proliferate as effectively, making lymph nodes essential for a strong immune response and successful immunotherapy. Professor Axel Kallies said the findings have important implications for cancer therapy. "Lymph...
-
Listen to this story IN THE POPULAR imagination, cancer starts with a mutation in the DNA of a normal cell. That mutation allows the cell to multiply uncontrollably, circumventing the body’s usual quality-control checks. Eventually, a tumour forms and breakaway cells spread to other parts of the body. But in the past few years scientists have been finding something surprising—so-called cancer-driver mutations are also common in healthy tissue. Such mutations appear in around a quarter of healthy skin cells. When a person is middle aged more than half the surface of the oesophagus and nearly 10% of the lining of...
|
|
|